To see the other types of publications on this topic, follow the link: Teste Hpv.

Books on the topic 'Teste Hpv'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 45 books for your research on the topic 'Teste Hpv.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Chandani, Yasmin. Quantification of HIV tests and ARV drugs for Zimbabwe's MOHCW Program: 2007-2008. Arlington, VA: Supply Chain Management System, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Swift, Yasgur Batya, and Warshowsky Allan, eds. Women at risk: The HPV epidemic and your cervical health. New York: Avery, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Heart rate variability (HRV) signal analysis: Clinical applications. Boca Raton: Taylor & Francis, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Leitner, Michael. Mythos HIV: Eine kritische Analyse der AIDS-Hysterie ; verfälschte Statistiken, trickreiche Virusnachweise, untaugliche Tests und illegale Medikamente. Niebüll: Videel, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

System, Supply Chain Management. Quantification of HIV tests and ARV drugs for Zimbabwe's MOHCW program: A summary for policy makers (2007-2008). Arlington, VA: Supply Chain Management System, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pfeffer, Hans. Durchführung von HIV-Tests ohne den Willen des Betroffenen: Pflicht und Befugnis zur Befundmitteilung aus der Sicht des Strafrechts. Berlin: Duncker & Humblot, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Levin, Jules. Perspectives on viral load (HIV RNA) and when to initiate therapy: A discussion of data, how to use viral load tests, how to interpret test results. Brooklyn, NY (72 Orange St., #3C, Brooklyn 11201): National AIDS Treatment Advocacy Project, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Guillod, Olivier. Drei Gutachten über rechtliche Fragen im Zusammenhang mit AIDS: Fragen der Partnernotifikation, des Contact Tracing und der HIV-Tests aus der Sicht des Verfassungs- und Verwaltungsrechts, des Zivilrechts und des Strafrechts. Bern: Stämpfli & Cie, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

McNerney, Ruth. Evaluation of the role of nucleic acid amplification tests in the routine diagnosis of tuberculosis in developing countries with a high prevalence of HIV infection: Report of a three year collaborative research project (1996-1999). Lusaka: s.n., 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

United States. Dept. of Veterans Affairs, ed. Veterans have stood the tests of time: Now get tested again. [Washington, D.C.]: Dept. of Veterans Affairs, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Young, Thomas P. Laboratory Testing Strategies. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0008.

Full text
Abstract:
Laboratory confirmation of HIV infection is primarily through the detection of HIV antibodies in an individual. Using the current immunoassays and confirmatory testing, false-positive results are exceedingly rare. However, providers should use clinical judgment when interpreting test results and consider additional follow-up testing when appropriate. False-negative immunoassays are also exceedingly rare except for individuals who are early in their infection and have yet to produce HIV antibodies that are detectable by current assays. Rapid HIV tests have similar testing accuracies as compared to those of currently available immunoassays and can be useful testing options for settings such as health fairs, nonclinical locations, and other situations in which quickly receiving preliminary test results would be beneficial.
APA, Harvard, Vancouver, ISO, and other styles
12

Be corageous again: Get tested. [Washington, D.C.]: Dept. of Veterans Affairs, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Jadoul, Michel, Laura Labriola, and Eric Goffin. Viral infections in patients on dialysis. Edited by Jonathan Himmelfarb. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0271.

Full text
Abstract:
From the early days of hemodialysis, viral hepatitis has been recognized as common in dialyzed patients.The prevalence and incidence of HBV infection have decreased markedly over the last decades in HD units. Still, the infectivity of HBV is very high. Vaccinating HD patients, preferably prior to starting dialysis, together with the strict application of hygienic precautions and adequate screening of blood donors remains required, together with the segregation of infective (HBV+) patients in a separate dialysis ward. The level of aminotransferases is markedly lower in HD patients than in the general population: any level above the normal range should thus trigger the suspicion of acute hepatitis (viral or not). The treatment of HBV infection in HD patients is rarely required, unless they are scheduled for a kidney transplant.Screening for HCV infection usually relies on a modern ELISA test. The prevalence and incidence of HCV infection in HD patients has also decreased substantially but remains higher than in the general population. The risk of post-transfusional HCV is currently extremely low, at least in western countries. The actual application of basic hygienic precautions is crucial if nosocomial transmission of HCV is to be prevented. These include optimal hand hygiene practices (hydroalcoholic solution use before contact with patient and after gloves withdrawal), the systematic wearing of gloves, to be changed between patients/stations, an adequate separation of the clean and contaminated items and circuits within the HD unit, and regular cleaning/disinfection of potentially contaminated surfaces. The necessity and usefulness to isolate HCV positive patients in a separate dialysis ward has not been demonstrated and is not recommended by current KDIGO guidelines. The field of the treatment of HCV infection is changing rapidly with many orally active drugs, some of which can be used even in dialysis patients.
APA, Harvard, Vancouver, ISO, and other styles
14

Thomas, Paul S., and Marc Lipman. Visual Diagnosis Self-tests on HIV Medicine (Visual Diagnosis Self-Tests). Merit Publishing International, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Hansoti, Bhakti. Pulmonary Tuberculosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0028.

Full text
Abstract:
Mycobacterium tuberculosis (TB) is most commonly known for its manifestations in the lungs; symptoms include fever and chest pain (retrosternal pain and/or dull intracapsular pain). In the reactivation stage of TB, typical symptoms may include cough, weight loss, fatigue, fever, night sweats, chest pain, dyspnea, and/or hemoptysis. Symptoms may remain undiagnosed for several years. Poverty, HIV, and drug resistance are major contributors to the resurging global TB epidemic. Two kinds of tests are used to detect TB: the tuberculin skin test or a TB blood test. These tests only tell you if a person has been infected with the bacteria. The do not differentiate between latent TB infection and active TB. This distinction clinically suspected when the clinical picture of active TB matches with initial investigations (such as acid-fast bacilli stains, chest x-ray, or CT) and is definitively confirmed by the growth of M. tuberculosis in a clinical specimen.
APA, Harvard, Vancouver, ISO, and other styles
16

" HIV test" manufacturers admit their tests are invalid. Toronto: HEAL<, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Tucker, Joan, Suzanne Wenzel, Marc Elliott, Katrin Hambarsoomian, and Daniela Golinelli. HIV Testing Among Indigent Women: Who Gets Tested? RAND Corporation, 2005. http://dx.doi.org/10.7249/rb9103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Beattie, R. Mark, Anil Dhawan, and John W.L. Puntis. Hepatitis C. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569862.003.0058.

Full text
Abstract:
Epidemiology 424Risk of transmission 424Clinical features 424Specific viral tests 425Diagnosis of HCV infection in infants born to HCV +ve mother 425Management 425• Hepatitis C virus (HCV) is an RNA virus of the flaviviride family.• More than 150 million people are infected with HCV worldwide....
APA, Harvard, Vancouver, ISO, and other styles
19

What Your Doctor May Not Tell You about HPV and Abnormal Pap Smears. Grand Central Publishing, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Martagon-Villamil, Jose, and Daniel J. Skiest. Initial Laboratory Evaluation and Risk Stratification of the HIV-Infected Patient. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0010.

Full text
Abstract:
To adequately understand the HIV-infected individual’s stage of disease, risk profile, and management needs, a series of laboratory tests must be performed. Essential tests include CD4+ count, HIV viral load, HIV resistance assay, and serologic evaluation for certain opportunistic infections. The availability and indication for many of these may be influenced by cost considerations, especially in resource-limited settings. Baseline laboratory evaluation of all patients with HIV newly engaged in care must be done. In stable patients with suppressed viral load, CD4 count monitoring is only required at 6- to 12-month intervals. In stable patients with virologic suppression for 2 years or more, viral load monitoring can be decreased to every 6 months.
APA, Harvard, Vancouver, ISO, and other styles
21

Wilson, John W., and Lynn L. Estes. Antiretroviral Therapy for HIV Infection. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199797783.003.0134.

Full text
Abstract:
• Obtain confirmatory human immunodeficiency virus (HIV) testing by rapid test or enzyme-linked immunosorbent assay (ELISA); optimally repeat HIV viral load (VL) and CD4 T-cell (CD4) count 2 times before initiation of therapy; a substantial change in CD4 count is generally >30%• Perform VL immediately before treatment initiation (or change in therapy) and again 2–8 weeks later; for the latter, the optimal decrease would be at least 1 log...
APA, Harvard, Vancouver, ISO, and other styles
22

Delgado, Alejandro, and William P. Mazur. HIV Testing and Counseling. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0007.

Full text
Abstract:
It is estimated that approximately 14% of people living with HIV are unaware of their diagnosis. Thus, HIV testing should be offered as part of routine medical care to all patients. In 2013, the US Preventive Services Task Force formally recommended that clinicians screen all patients between the ages of 15 and 65 years. Testing in younger and older patients should be offered when special circumstances deem this appropriate. All persons screened for HIV should be counseled regarding risk-reduction strategies regardless of test result. All pregnant women should be screened for HIV at the earliest instance possible. HIV screening should be voluntary and undertaken only with the patient’s knowledge and understanding.
APA, Harvard, Vancouver, ISO, and other styles
23

STI/ HIV Laboratory Tests for the Detection of Reproductive Tract Infections. WHO Regional Office for the Western Pacific, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Cocohoba, Jennifer. The Pharmacist’s Role in Caring for HIV-Positive Individuals. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0024.

Full text
Abstract:
Medications for HIV have become more convenient but not less complex. For this reason, having a clinical pharmacist as a part of the health care team can greatly enhance the care of HIV-positive patients. HIV pharmacists are a diverse group of providers who work to improve the health of HIV-positive individuals via medication therapy management, quality assurance practices, research, and other avenues. HIV pharmacists may be particularly skilled at managing complex antiretroviral drug–drug interactions, recommending therapies for resistant HIV virus, and providing education and support with regard to adherence. If practicing with a physician under a collaborative drug therapy management agreement, an HIV pharmacist may be able to provide more direct management (e.g., prescribing and ordering lab tests) for HIV and its associated conditions.
APA, Harvard, Vancouver, ISO, and other styles
25

Martagon-Villamil, Jose, and Daniel J. Skiest. Clinical Syndromes and Differential Diagnosis in the HIV-Infected Patient. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0011.

Full text
Abstract:
Acute HIV infection is often missed but should be recognized. Most chronically infected individuals are asymptomatic. However, some patients with chronic HIV infection may present with certain clinical and laboratory abnormalities prior to the diagnosis of an opportunistic infection. HIV wasting syndrome is infrequently diagnosed in the era of antiretroviral therapy (ART). Recognition of HIV wasting is important because it carries adverse prognostic implications. Management includes a multifaceted approach, including ART, lifestyle and nutritional support, appetite stimulation, and possibly hormonal agents. The newer antigen–antibody test can detect new HIV infection as early as 15 days after exposure. Screening is important because most chronic HIV infection is asymptomatic.
APA, Harvard, Vancouver, ISO, and other styles
26

Mutyambizi, Kudakwashe. Dermatologic Complications. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0034.

Full text
Abstract:
The hallmark of HIV infection is immune dysregulation and immunosuppression. As the immune system deteriorates, inflammatory dermatoses, metabolic dysregulation, adverse drug reactions, opportunistic infections, and cutaneous malignancies become more common, atypical in presentation, and recalcitrant to therapy. Both acute and chronic skin complaints contribute significantly to reduced quality of life for HIV patients. The Centers for Disease Control and Prevention recommends that individuals between ages 13 and 64 years be tested for HIV at least once in their lifetime, with increased screening of high-risk individuals and testing based on symptoms. The presence of dermatoses uncommon in the general population but concentrated in the HIV population, or dermatoses strikingly recalcitrant to therapy, should warrant suspicion and testing for HIV.
APA, Harvard, Vancouver, ISO, and other styles
27

Keltner, John R., Cherine Akkari, and Ronald J. Ellis. Neurological Complications of HIV in The Peripheral Nervous System. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0027.

Full text
Abstract:
HIV sensory neuropathy affects approximately 50% of persons diagnosed with HIV and, in 40%, results in disabling symptoms including paresthesia and/or pain. This chapter focuses on providing guidance to psychiatrists in the clinical management of pain in persons with HIV and sensory neuropathy. The differential diagnostic evaluation of HIV sensory neuropathy, other peripheral neuropathies, and spinal cord mimics and management of HIV sensory neuropathy are reviewed, as well as management of HIV distal neuropathic pain. The differential diagnostic evaluation of peripheral neuropathies is simplified using a graphical decision tree. The chapter also reviews the pathophysiology of HIV sensory neuropathy and warning signs of advanced disease. Procedures to diagnose HIV sensory neuropathy, including nerve conduction studies and electromyography, quantitative sensory testing, skin biopsy, and the autonomic sweat test are discussed, as are clinical aspects of HIV distal neuropathic pain. The chapter addresses the impact of HIV distal neuropathic pain on quality of life and depression and concludes with a discussion of treatments for HIV distal neuropathic pain.
APA, Harvard, Vancouver, ISO, and other styles
28

Thornton, Rebecca L., and Hans-Peter Kohler. Making Marriages Last. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198829591.003.0003.

Full text
Abstract:
Economists have examined investments under uncertainty in a variety of contexts. Becker et al. applied the idea to marriage and divorce, suggesting that an increased likelihood of separation or divorce reduces the incentive for spouses to invest in marriage-specific assets. This theory has since been tested empirically by measuring changes in investments in marriage-specific capital. In high HIV-prevalence contexts, marriage can lead to significant risks through spousal behaviours. Yet, individuals cannot rely on their spouse to reveal their HIV status. Couples’ HIV testing and counselling can provide spouses with credible information about each other’s HIV status. Using random variation in participation in couples’ testing, this chapter documents that uncertainty about spouses’ HIV status contributes to divorce. Innovations, such as HIV couples’ testing and counselling—and, in the future, possibly rapid self-testing—that reduce this uncertainty can thus have profound impacts on marital behaviours and stability.
APA, Harvard, Vancouver, ISO, and other styles
29

Handley, Jody, and Joel Palefsky. What Your Doctor May Not Tell You about HPV and Abnormal Pap Smears: Get the Facts on This Dangerous Virus-Protect Your Health and Your Life! Grand Central Publishing, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Kulkarni, Kunal, James Harrison, Mohamed Baguneid, and Bernard Prendergast, eds. Genitourinary medicine. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198729426.003.0009.

Full text
Abstract:
In the UK, the continued rise in sexually transmitted infections remains a key public health concern. Since the advent of HIV infection, many genitourinary medicine specialists have also undertaken the management of HIV and AIDS, and there has been a move towards closer links or integration with contraception/family planning under the umbrella of sexual health, creating a continually shifting and developing field. Advances in diagnostic technology, such as the recent nucleic acid amplification tests for gonorrhoea, continue to make this specialty as fascinating and satisfying as ever, combining the science of medicine with the art of clinical practice. This chapter covers some of these recent advances, focusing on the key clinical evidence currently shaping this specialty.
APA, Harvard, Vancouver, ISO, and other styles
31

Worthington, Catherine A. Being tested: An investigation of recipient perspectives on HIV testing services using a multi-method approach. 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Norum, Allison. Evaluation of the relationship between liver function tests and serum zidovudine pharmacokinetic parameters in HIV-positive individuals. 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Bicanic, Tihana, and Thomas S. Harrison. Fungal central nervous system infections. Edited by Christopher C. Kibbler, Richard Barton, Neil A. R. Gow, Susan Howell, Donna M. MacCallum, and Rohini J. Manuel. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755388.003.0022.

Full text
Abstract:
Infections of the central nervous system (CNS) are amongst the most severe of all fungal infections. Cryptococcus neoformans is the commonest cause of adult meningitis in many countries with high HIV prevalence. C gattii is usually seen in the tropics in apparently immunocompetent patients. Meningitis is also caused by Candida in premature babies, and by the dimorphic fungi in endemic areas. CNS infections with Aspergillus, the mucormycetes, and less common moulds usually present as intracranial mass lesions in immunocompromised hosts. Early suspicion, prompt imaging, and appropriate samples for culture, histology, and antigen and molecular tests are all critical for early diagnosis. Organism-specific antifungal therapy relies largely on liposomal amphotericin B and voriconazole, with therapeutic drug monitoring for the latter. Amphotericin B plus flucytosine is recommended for cryptococcal meningitis. Management of underlying conditions is also critical. Targeted prophylaxis in highest risk groups and pre-emptive therapy for HIV-associated cryptococcosis hold promise for prevention and improved outcome.
APA, Harvard, Vancouver, ISO, and other styles
34

Cohen, Mary Ann, Harold Goforth, Joseph Lux, Sharon Batista, Sami Khalife, Kelly Cozza, and Jocelyn Soffer. Handbook of AIDS Psychiatry. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195372571.001.0001.

Full text
Abstract:
The Handbook of AIDS Psychiatry is a practical guide for AIDS psychiatrists and other mental health professionals as well as for other clinicians who work with persons with HIV and AIDS and a companion book to the Comprehensive Textbook of AIDS Psychiatry (Cohen and Gorman, 2008). The Handbook provides insights into the dynamics of adherence to risk reduction and medical care in persons with HIV and AIDS as well as strategies to improve adherence using a biopsychosocial approach. Psychiatric disorders can accelerate the spread of the virus by creating barriers to risk reduction. Risky sexual behaviors and sharing of needles in intravenous drug users account for the majority of new cases each year. Delirium, dementia, depression, substance dependence, PTSD, and other psychiatric disorders complicate the course and add considerably to the pain and suffering of persons with AIDS. HIV infection and AIDS also are risk factors for suicide, and the rate of suicide has been shown to be higher in persons with AIDS. Psychiatric care can help prevent HIV transmission through recognition and treatment of substance-related disorders, dementia, and mood disorders such as mania. Comprehensive, coordinated care by a multidisciplinary AIDS team, including AIDS psychiatrists, can provide a biopsychosocial approach that is supportive to patients, families, and clinicians. Psychiatric interventions are valuable in every phase of infection, from identification of risk behaviors to anticipation about HIV testing; from exposure and initial infection to confirmation with a positive HIV antibody test; from entry into systems of care to managing complex antiretroviral regimen; from healthy seropositive to onset of first AIDS-related illness; from late stage AIDS to end-stage AIDS and death. There is no comprehensive handbook of AIDS psychiatry to guide clinicians in providing much needed care. The Handbook of AIDS Psychiatry is a practical pocket guide that provides protocols for the recognition and treatment of the psychiatric disorders most prevalent in persons with AIDS and most relevant for primary physicians, infectious disease specialists, and other caregivers because of their impact on health, adherence, behavior, and quality of life.
APA, Harvard, Vancouver, ISO, and other styles
35

1969-, Bennett Rebecca, and Erin Charles A, eds. HIV and AIDS: Testing, screening, and confidentiality. Oxford: Oxford University Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Lester, Rebecca, and John Rex. Fungaemia and disseminated infection. Edited by Christopher C. Kibbler, Richard Barton, Neil A. R. Gow, Susan Howell, Donna M. MacCallum, and Rohini J. Manuel. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755388.003.0025.

Full text
Abstract:
Invasive fungal disease can present without localization or obvious target organ involvement. These disseminated mycoses occur predominantly in patients who are immunocompromised, particularly from haematological malignancy and HIV. Candidiasis and aspergillosis are the commonest forms of disseminated fungal infection worldwide, but an increasing number of non-Candida yeasts and non-Aspergillus moulds have emerged as important causes of invasive disease in recent years. Endemic fungi such as Histoplasma capsulatum are important causes of invasive disease within limited geographic regions. Fever is the commonest manifestation of disseminated fungal infection, but other clinical features such as cutaneous manifestations may point to a specific diagnosis. Definitive diagnosis relies on the detection of fungi in tissue or blood, but serological tests can augment diagnosis in some infections. Mortality from disseminated fungal disease is high and prompt initiation of antifungal therapy—where invasive disease is suspected—is essential.
APA, Harvard, Vancouver, ISO, and other styles
37

M, Hardy Leslie, and Institute of Medicine (U.S.). Committee on Prenatal and Newborn Screening for HIV Infection., eds. HIV screening of pregnant women and newborns. Washington, D.C: National Academy Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

HIV Screening of Pregnant Women And Newborns. Natl Academy Pr, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Woywodt, Alexander, and Diana Chiu. The glomerulus and the concept of glomerulonephritis. Edited by Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0042.

Full text
Abstract:
The key features of glomerular diseases—haematuria, proteinuria, loss of glomerular filtration rate, and hypertension—were recognized in the nineteenth century, and some earlier, but Richard Bright is usually given credit for synthesizing the concepts of renal disease, and glomerulonephritis came under the heading of Bright’s disease for almost a century. Separation into different types was based on first clinical syndromes, but in the early twentieth century, pathological description was improving and with the introduction of percutaneous renal biopsies in the 1950s, in the 1960s histopathological definitions assumed the ascendancy. A unifying classification of glomerular disease remains work in progress. Current classifications are pathologically based but increasingly include the results of other investigations (including genotype and a variety of immunological and other tests). This chapter follows this pragmatic, hybrid approach, categorizing glomerular disease by pattern on renal biopsy except where aetiological factors are clearly identified (e.g. HIV nephropathy), or associated multisystem disease is defined (e.g. lupus nephritis), or the immunopathogenesis is well characterized (e.g. antiglomerular basement membrane disease).
APA, Harvard, Vancouver, ISO, and other styles
40

Melby, Carolyn Sue. RELATIONSHIPS AMONG PERCEIVED STIGMA AND ITS MANAGEMENT, THE DECISION TO BE TESTED FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV), AND HIGH RISK BEHAVIORS OF HOMOSEXUAL MALES (AIDS, SAFE SEX). 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Todd, Stacy, and Nick Beeching. Fungal infection. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0315.

Full text
Abstract:
Fungi, comprising yeasts, moulds, and higher fungi, have a worldwide distribution and are uncommon causes of disease in healthy individuals. However, over the last 20 years, invasive fungal disease (IFD) has become an increasing cause of morbidity and mortality. This is probably due to the increasing numbers of patients with underlying host conditions, which predispose to opportunistic IFD (e.g. transplant and anti-tumour necrosis factor immunosuppression, HIV, or chronic lung disease), and to increased recognition of endemic IFD (e.g. histoplasmosis), which cause disease in both immunocompetent and immunocompromised hosts in selected geographic locations. Diagnosis of IFD remains a challenge. Symptoms are often non-specific, and a definite diagnosis requires invasive sampling with appropriate laboratory testing of these samples. Non-invasive tests are being developed, but their positive and negative predictive values still need validation. Diagnostic criteria (‘proven, probable, and possible’) established primarily for use in research and clinical trials can also prove useful in clinical environments. However, the most important step in identifying patients with IFD is to consider the diagnosis in those at risk. This chapter will focus on the commonest causes of IFD (Candida spp., Aspergillus spp., Cryptococcus spp., and histoplasmosis).
APA, Harvard, Vancouver, ISO, and other styles
42

(Editor), Rebecca Bennett, and Charles A. Erin (Editor), eds. HIV and AIDS Testing, Screening, and Confidentiality (Issues in Biomedical Ethics). Oxford University Press, USA, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Alexandrova, Anna. Pregnant women and the testing for HIV-infection: Can the practice of coercive testing be supported by public health concerns when weighed against the privacy interests of those tested : experience of Canada, Russian Federation and the United States. 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Shephard OAM, Mark, ed. Practical Guide to Global Point-of-Care Testing. CSIRO Publishing, 2016. http://dx.doi.org/10.1071/9781486305193.

Full text
Abstract:
Point-of-care testing (POCT) refers to pathology testing performed in a clinical setting at the time of patient consultation, generating a rapid test result that enables informed and timely clinical action to be taken on patient care. It offers patients greater convenience and access to health services and helps to improve clinical outcomes. POCT also provides innovative solutions for the detection and management of chronic, acute and infectious diseases, in settings including family practices, Indigenous medical services, community health facilities, rural and remote areas and in developing countries, where health-care services are often geographically isolated from the nearest pathology laboratory. A Practical Guide to Global Point-of-Care Testing shows health professionals how to set up and manage POCT services under a quality-assured, sustainable, clinically and culturally effective framework, as well as understand the wide global scope and clinical applications of POCT. The book is divided into three major themes: the management of POCT services, a global perspective on the clinical use of POCT, and POCT for specific clinical settings. Chapters within each theme are written by experts and explore wide-ranging topics such as selecting and evaluating devices, POCT for diabetes, coagulation disorders, HIV, malaria and Ebola, and the use of POCT for disaster management and in extreme environments. Figures are included throughout to illustrate the concepts, principles and practice of POCT. Written for a broad range of practicing health professionals from the fields of medical science, health science, nursing, medicine, paramedic science, Indigenous health, public health, pharmacy, aged care and sports medicine, A Practical Guide to Global Point-of-Care Testing will also benefit university students studying these health-related disciplines.
APA, Harvard, Vancouver, ISO, and other styles
45

Tong, Cheuk Yan William, Caryn Rosmarin, and Armine Sefton, eds. Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.001.0001.

Full text
Abstract:
Microbiology and virology laboratories provide a diagnostic service that supports the management of patients under the care of front-line clinicians. Despite the significant overlap, laboratory expertise and clinical patient management are traditionally viewed as independent entities. Trainees in the infection disciplines of microbiology, virology, infectious diseases, and tropical medicine have until recently received separate, and as a result, limited training. To address this problem, the UK replaced the FRCPath Part 1 examination for infectious disease trainees with a combined infection training (CIT) curriculum in 2015. Based on the idea of integration and collaboration within the field, CIT links laboratory expertise to clinical patient management. Tutorial Topics in Infection for the Combined Infection Training Programme is the first book covering the complete CIT curriculum. Following the format of the CIT certificate examination, each chapter ends with three single best answer multiple choice questions accompanied by in-depth discussions. This extensive content helps students appreciate the breadth of knowledge required, emphasises how the different aspects of the field are related, and is an essential tool for those preparing for the CIT certificate examination. Written by a multi-disciplinary team of medical microbiologists, virologists, infectious disease physicians, clinical scientists, biomedical scientists, public health specialists, HIV clinicians, and infection control nurses, this well-illustrated and easy to use book offers a unique insight into infectious diseases. It is the perfect primer for further study, a starting point for medical students and professionals wishing to learn more about the different topics within the infection specialty, and ideal for biomedical scientists looking to broaden their clinical understanding of the field beyond the diagnostic test.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography